My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Severe asthma and the omalizumab option.

    Miller CW, Krishnaswamy N, Johnston C, Krishnaswamy G.

    Clin Mol Allergy. 2008 May 20;6:4.PMID: 18489791 [PubMed - in process]Related articlesFree article

    2.

    [Omralizumab (Xolair) in severe persistent allergic asthma]

    Schleich F, Manise M, Louis R.

    Rev Med Liege. 2009 May-Jun;64(5-6):313-7. French. PMID: 19642466 [PubMed - indexed for MEDLINE]Related articles

    3.

    A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

    D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

    Recent Pat Inflamm Allergy Drug Discov. 2007;1(3):225-31. Review.PMID: 19075985 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).

    D'Amato G, Bucchioni E, Oldani V, Canonica W.

    Treat Respir Med. 2006;5(6):393-8.PMID: 17154668 [PubMed - in process]Related articles

    5.

    A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.

    D'Amato G, Salzillo A, Piccolo A, D'Amato M, Liccardi G.

    Ther Clin Risk Manag. 2007 Aug;3(4):613-9.PMID: 18472983 [PubMed - in process]Related articlesFree article

    6.

    Anti-IgE antibodies for the treatment of asthma.

    Buhl R.

    Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.PMID: 15591885 [PubMed - indexed for MEDLINE]Related articles

    7.

    Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.

    Nowak D.

    Respir Med. 2006 Nov;100(11):1907-17. Epub 2006 Sep 1. Review.PMID: 16949266 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of omalizumab on markers of inflammation in patients with allergic asthma.

    Holgate S, Smith N, Massanari M, Jimenez P.

    Allergy. 2009 Dec;64(12):1728-36. Epub 2009 Oct 15. Review.PMID: 19839977 [PubMed - indexed for MEDLINE]Related articles

    9.

    Omalizumab : other indications and unanswered questions.

    Mankad VS, Burks AW.

    Clin Rev Allergy Immunol. 2005 Aug;29(1):17-30. Review.PMID: 16222081 [PubMed - indexed for MEDLINE]Related articles

    10.

    Omalizumab: a review of its use in the treatment of allergic asthma.

    Plosker GL, Keam SJ.

    BioDrugs. 2008;22(3):189-204. Review.PMID: 18481901 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Anti-IgE therapy in persistent allergic asthma]

    Skiepko R, Zietkowski Z, Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A.

    Przegl Lek. 2009;66(3):141-4. Review. Polish. PMID: 19689039 [PubMed - indexed for MEDLINE]Related articles

    12.

    Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.

    Félix Toledo R, Negro Alvarez JM, Miralles López JC.

    Allergol Immunopathol (Madr). 2002 Mar;30(2):94-99.PMID: 11958741 [PubMed - as supplied by publisher]Related articlesFree article

    13.

    Current and future applications of the anti-IgE antibody omalizumab.

    Incorvaia C, Mauro M, Riario-Sforza GG, Frati F, Tarantini F, Caserini M.

    Biologics. 2008 Mar;2(1):67-73.PMID: 19707429 [PubMed - in process]Related articlesFree article

    14.

    Omalizumab: new drug. Asthma: too many unknowns for an anti-IgE.

    [No authors listed]

    Prescrire Int. 2007 Oct;16(91):179-82.PMID: 17926440 [PubMed - indexed for MEDLINE]Related articles

    15.

    What is new in antiimmunoglobulin E asthma therapy.

    Berger WE.

    Allergy Asthma Proc. 2005 Nov-Dec;26(6):428-34. Review.PMID: 16541964 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.

    Busse WW, Massanari M, Kianifard F, Geba GP.

    Curr Med Res Opin. 2007 Oct;23(10):2379-86.PMID: 17711616 [PubMed - indexed for MEDLINE]Related articles

    17.

    Omalizumab: efficacy in allergic disease.

    Spector S.

    Panminerva Med. 2004 Jun;46(2):141-8. Review.PMID: 15507883 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Evaluation of omalizumab from a health plan perspective.

    Belliveau PP, Lahoz MR.

    J Manag Care Pharm. 2005 Nov-Dec;11(9):735-45. Review.PMID: 16300417 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Omalizumab in the treatment of severe asthma: efficacy and current problems.

    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.

    Ther Adv Respir Dis. 2008 Dec;2(6):409-21. Review.PMID: 19124386 [PubMed - indexed for MEDLINE]Related articles

    20.

    Does anti-IgE therapy help in asthma? Efficacy and controversies.

    Avila PC.

    Annu Rev Med. 2007;58:185-203. Review.PMID: 17059361 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk